APEX1 and non-small cell lung carcinoma: This study is a prospective, randomized clinical trial to assess whether gossypol can enhance the efficacy of docetaxel and cisplatin in patients with high expression of APE1, to provide a new target for targeted chemotherapy of NSCLC and to test a safe and economical combination of drugs to improve the efficacy of advanced NSCLC chemotherapy.